¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼® - ¼­ºñ½ºº°, °ø±Þ¿øº°, Á¦Ç°º°, Áö¿ªº° ¿¹Ãø(2025-2035³â)
Global Biopharmaceutical Contract Manufacturing Market Size Study & Forecast, by Service, Source and Product and Regional Forecasts 2025-2035
»óǰÄÚµå : 1799537
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,951,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,777,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ ¾à 166¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£(2025-2035³â) Áß CAGR 15.30%·Î °ßÁ¶ÇÏ°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶´Â »ý¹° Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ »ý»ê, ºÐ¼® ½ÃÇè, Æ÷Àå, ǰÁú °ü¸® ¼­ºñ½º¸¦ Àü¹® Á¦3ÀÚ ½Ã¼³¿¡ ¾Æ¿ô¼Ò½ÌÇÏ´Â °ÍÀ» Æ÷°ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ºñÁî´Ï½º ÇÕ¸®È­, ÀÚº» ÁöÃâ °¨¼Ò, º¹ÀâÇÑ Ä¡·áÁ¦ ½ÃÀå Ãâ½Ã ±â°£ ´ÜÃàÀ» ¸ñÇ¥·Î ÇÏ´Â Á¦¾à ±â¾÷¿¡ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º Áúȯ Áõ°¡, »ý¹° Á¦Á¦ ÆÄÀÌÇÁ¶óÀÎÀÇ È®´ë, ºñ¿ë È¿À²ÀûÀ̰í È®Àå °¡´ÉÇÑ Á¦Á¶ ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

»ý¹° Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ ¼ö¿ä Áõ°¡´Â °íǰÁúÀÇ Á¦Á¶ ±âÁØÀ» ¿ä±¸ÇÏ´Â ±ÔÁ¦ ¾Ð·Â Áõ°¡¿Í ÇÔ²² Àü¹®ÀûÀÎ ¼öŹ Á¦Á¶ ¼­ºñ½ºÀÇ Çʿ伺À» ÇöÀúÇÏ°Ô Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. Á¦Á¶¾÷¹«¸¦ ¾Æ¿ô¼Ò½ÌÇÔÀ¸·Î½á Á¦¾àȸ»ç´Â Á¦Á¶¼öʱâ°ü(CMO)ÀÇ ±â¼úÀû Àü¹®Áö½ÄÀ» Ȱ¿ëÇϸ鼭 ¿¬±¸°³¹ß, »óǰȭ¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ±Ù ¾÷°è º¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ »ý¹° Á¦Á¦ ½ÃÀåÀº Çõ½ÅÀûÀÎ Ä¡·á¹ý°ú ȯÀÚ ¼öÀÇ È®´ë¿¡ °ßÀεǾî CMO¿¡ Å« ºñÁî´Ï½º ±âȸ¸¦ °¡Á®¿À°í ¾ÕÀ¸·Îµµ »ó½Â ±âÁ¶¸¦ °è¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷ÁÖ °³¹ß, °øÁ¤ ÃÖÀûÈ­, ÀÚµ¿È­ ±â¼úÀÇ Áøº¸°¡ ÀÌ ºÐ¾ß ÀüüÀÇ Á¦Á¶ È¿À²°ú °¡µ¿·üÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®¿¡ µû¸£¸é ºÏ¹Ì´Â ¼º¼÷ÇÑ Á¦¾à »ýŰè, ÁÖ¿ä CMOÀÇ Á¸Àç, Áö¿ø ±ÔÁ¦ ÀÎÇÁ¶ó µîÀ¸·Î ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ÀÇ ÁÖ¿ä ½ÃÀåÀÌ µÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº ´ë±Ô¸ð ¿¬±¸°³¹ß ÅõÀÚ, ÷´Ü »ý»ê ½Ã¼³, »ý¹° Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯¿¡ ´ëÇÑ ¿Õ¼ºÇÑ ¼ö¿äÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹¿¡ ÀǾàǰ Çãºê°¡ È®¸³µÇ¾î ÀÖ´Â À¯·´µµ °íǰÁúÀÇ Á¦Á¶¿Í ¾ö°ÝÇÑ ÄÄÇöóÀ̾𽺠±âÁØÀ» Áß½ÃÇϰí ÀÖÀ¸¸ç, Å« °øÇåÀ» Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ Áõ°¡, »ý¹°Á¦Á¦ ä¿ë Áõ°¡, Áß±¹°ú Àεµ µî ±¹°¡¿¡¼­ÀÇ »ý»ê´É·Â È®´ë, ÀǾàǰ ¼öÃâÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ È£ÀÇÀûÀÎ Á¤Ã¥¿¡ ÈûÀÔ¾î ¿¹Ãø±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â ÀÇ·á ÀÎÇÁ¶ó ¼ºÀå, ¹ÙÀÌ¿À ÀǾàǰ »ý»ê ÅõÀÚ Áõ°¡, °æÁ¦ÀûÀÎ »ý¹° Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À¯¸®ÇÑ ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ¸ñÀûÀº ÃÖ±Ù ¿©·¯ ºÎ¹® ¹× ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â ºÐ¼® ´ë»ó ±¹°¡¿¡¼­ ¾÷°èÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½ÃÀå Àü¸Á ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃßÁø ¿äÀΰú µµÀü°ú °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ »ó¼¼ÇÑ ºÎ¹®¿Í ÇÏÀ§ ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå : ºÐ¼® ¹üÀ§ ¹× ¼ö¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå : ¿ªÇÐ ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : ¼­ºñ½ºº°(2025-2035³â)

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : °ø±Þ¿øº°(2025-2035³â)

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : Á¦Ç°º°(2025-2035³â)

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ ¼öŹ Á¦Á¶ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø : Áö¿ªº°(2025-2035³â)

Á¦9Àå °æÀï Á¤º¸

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Biopharmaceutical Contract Manufacturing Market is valued at approximately USD 16.65 billion in 2024 and is projected to expand at a robust CAGR of 15.30% over the forecast period 2025-2035. Biopharmaceutical contract manufacturing encompasses the outsourcing of production, analytical testing, packaging, and quality control services for biologics and biosimilars to specialized third-party facilities. These services are increasingly critical for pharmaceutical companies aiming to streamline operations, reduce capital expenditures, and accelerate time-to-market for complex therapeutics. The growth of the market is predominantly fueled by the rising prevalence of chronic diseases, the expansion of the biologics pipeline, and an intensified focus on cost-effective, scalable manufacturing solutions.

Escalating demand for biologics and biosimilars, coupled with increasing regulatory pressures for high-quality manufacturing standards, has significantly amplified the need for specialized contract manufacturing services. Outsourcing production operations allows pharmaceutical companies to focus on research, development, and commercialization while leveraging the technical expertise of contract manufacturing organizations (CMOs). According to recent industry reports, the global biologics market is expected to continue its upward trajectory, driven by innovative therapies and an expanding patient population, creating substantial opportunities for CMOs. Furthermore, advances in cell line development, process optimization, and automation technologies are reshaping manufacturing efficiencies and capacity utilization across the sector.

Regional insights reveal that North America remains the dominant market for biopharmaceutical contract manufacturing due to its mature pharmaceutical ecosystem, presence of leading CMOs, and supportive regulatory infrastructure. The United States, in particular, benefits from extensive R&D investment, advanced production facilities, and robust demand for biologics and biosimilars. Europe, with established pharmaceutical hubs in Germany, France, and the UK, is also a significant contributor, emphasizing high-quality manufacturing and stringent compliance standards. Meanwhile, Asia Pacific is anticipated to witness the fastest growth over the forecast period, fueled by increasing healthcare expenditures, rising biologics adoption, expansion of manufacturing capacities in countries like China and India, and favorable government policies promoting pharmaceutical exports. Latin America and the Middle East & Africa are emerging as lucrative markets due to growing healthcare infrastructure, increasing biopharmaceutical production investments, and rising demand for affordable biologics.

Major market players included in this report are:

Global Biopharmaceutical Contract Manufacturing Market Report Scope:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Service:

By Source:

By Product:

By Region:

Key Takeaways:

Table of Contents

Chapter 1. Global Biopharmaceutical Contract Manufacturing Market Report Scope & Methodology

Chapter 2. Executive Summary

Chapter 3. Global Biopharmaceutical Contract Manufacturing Market Forces Analysis

Chapter 4. Global Biopharmaceutical Contract Manufacturing Industry Analysis

Chapter 5. Global Biopharmaceutical Contract Manufacturing Market Size & Forecasts by Service 2025-2035

Chapter 6. Global Biopharmaceutical Contract Manufacturing Market Size & Forecasts by Source 2025-2035

Chapter 7. Global Biopharmaceutical Contract Manufacturing Market Size & Forecasts by Product 2025-2035

Chapter 8. Global Biopharmaceutical Contract Manufacturing Market Size & Forecasts by Region 2025-2035

Chapter 9. Competitive Intelligence

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â